Dr. Jaume Mora Graupera is a pediatric oncologist specializing in the treatment of neuroblastomas, gliomas, Ewing's sarcomas, and Wilms' tumors. He is the Director of the Hematology Oncology Department and Developmental Tumors Laboratory at Sant Joan De Déu - Barcelona Children’s Hospital. He received his medical degree from the University of Barcelona, went on to complete specialty training in pediatrics and fellowships in pediatric hematology oncology and molecular pathology of pediatric cancer at Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center in the USA. He has won multiple awards and is a member of various medical organizations.
This doctor has experience in endocrine treatment, collaborating on studies aimed at overcoming resistance to hormone therapy. They have also been involved in numerous phase 1, 2 and 3 studies in breast and melanoma, which have led to the approval of new drugs in new indications. Their main area of interest lies in immunotherapy for melanoma treatment and patient care. They have participated in trials that have led to the approval of cdk4/6 palbociclib and ribociclib inhibitors in the first line of metastatic breast cancer, and Pembrolizumab in the first line of metastatic melanoma, as well as the combination of Nivolumab and Ipilimumab. They are a member of the Breast Cancer Unit and Melanoma Unit at the Vall d'Hebron University Hospital and the Vall d'Hebron Institute of Oncology. This doctor is an experienced oncologist with expertise in breast cancer and melanoma treatments, including endocrine therapy, immunotherapy, and patient care. They have been involved in numerous clinical trials leading to the approval of new drugs in new indications.
Children's Hematologist. Specialist in bone marrow transplantation
Oncologist, specialist in gastrointestinal cancer treatment
20 top ranked Chemotherapy doctors in the world are represented on this page. The list includes only verified specialists known for their experience and high success rates.
The ranking is composed according to the Bookimed patient reviews and considers the rating of hospitals where doctors practice.
Top 5 Chemotherapy doctors on Bookimed.com:
The specialist’s CV contains details about the doctor’s expertise and work experience, education, scientific research, and languages spoken. Compare information on several specialists, read carefully about their experience, success rates, and methods they apply. Make sure the chosen doctor has relevant experience in the treatment of a medical issue you are looking for. Read reviews of patients who had a consultation with the chosen specialist.
Famous Chemotherapy doctors have vast experience, continue education constantly, participate in professional associations and have positive feedback from patients treated.
The price for the consultation on Chemotherapy varies between experts and depends on certain factors, such as:
To schedule your visit, just submit a request on Bookimed.com. Our coordinator will contact you to discuss the time and details of the appointment, so everything will go smoothly.
We can help to find the right doctors for Chemotherapy if you have any difficulties with a choice. Bookimed services are free for patients ♥
Professor Bosch is a highly reputed leader in Chronic Lymphocytic Leukemia (CLL) and conducts clinical and basic research on CLL and other lymphoproliferative disorders, focusing on the molecular pathogenesis of CLL and new therapeutic approaches. He has published over 100 articles in prestigious journals and is a professor of haematology at the Vall d'Hebron University Hospital of Barcelona.
Doctor is a Medical Oncologist with expertise in angiogenesis, DNA repair mechanisms, and immunology. She has a degree in medicine from Complutense University of Madrid, a medical oncology MD from the same university, and a PhD from Univesidad Autonoma de Barcelona. She is a Co-Chair of the GEICO Group, Faculty member for the Gyn-Track in the European Society of Medical Oncology, Spanish Representative of GOG, Spanish representative in the Cervical Committee and Phase II Committee of the GCIG Group, and an active member of the American Society of Clinical Oncology, European Society of Medical Oncology, and the Spanish Association of Medical Oncology. She has authored over 100 publications and presentations.
Dr. Prat is a clinical scientist with expertise in breast cancer research, clinical trials, and gene expression. He has a MD degree from the University of Barcelona and completed a medical oncology fellowship at the Vall d'Hebron Institute of Oncology. He is Head of the Translational Genomics and Targeted Therapeutics in Solid Tumors Group at August Pi i Sunyer Biomedical Research Institute, President of the Board of Directors of SOLTI, and member of the Executive Committee of The Breast International Group. He has published 160 publications with 13.479 citations and is a Tenure-Track Professor of Barcelona University and Director of the Breast Pathology – Senology Master´s degree.
Dr. Joan Albanell Mestres is a highly experienced oncologist with an extensive educational and research background. He has completed his MBBS from University Autónoma de Barcelona and has led various research and oncology programs. He has published 120 articles in reputable journals with more than 9000 citations.
Dr. Francesc Cobo Valien graduated from the Faculty of Medicine of the University of Barcelona in 1990.
He received his specialization in oncohematology at the Hospital Clínic de Barcelona in 1995. He combined medical practice and research activities in the period 1996-2002.
He received his Doctor of Medicine degree from the University of Barcelona in 2002.
Dr. Kobo continues his research and has been awarded grants:
•Interdepartmental Commission for Innovation of the Generalitat de Catalunya
•Scholarship Fund Universitaria Agustí Pedro i Pons
•Farreras Valentí & Schering Plough School of Hematology Scholarship
•Award for the best report at the Council of the Spanish Hematology Association
•Grant from the Catalan Society of Hematology
Specialization:
•Lymphoma
•Acute leukemia
•Chronic leukemia
•Autoimmune pancytopenia
Dr. Verges graduated in Medicine and Surgery from the University of Barcelona in 1980 and moved to Boston (USA) to conduct basic research in ophthalmology, obtaining a PhD in Biology from Harvard University and defending his doctoral thesis on the mechanisms of tear secretion, which would become the basis for understanding the pathology of dry eye syndrome (thesis presented in Barcelona, 1983) and which earned him the National Research Prize (1983).
Currently, Dr. Carlos Verges carries out his professional activity as the Director of the Ophthalmology Service of the Dexéus University Hospital, together with his entire medical team from the advanced ophthalmology department, where he has a high-quality technological, medical and surgical team.
His area of interest is focused on the field of cataract and neurophysiological mechanisms of vision, especially in relation to sports.
Professional experience
1983-1986 Associate Professor, Department of Ophthalmology, Faculty of Medicine, University of Barcelona, Spain
1986-1989 Head of the Anterior Segment Unit, Department of Ophthalmology, Barcelona Hospital Clinic, Spain.
1986-1991 Professor of Ophthalmology, Faculty of Medicine, University of Barcelona, Spain.
1990-1992 Head of Ophthalmology Service, Hospital del Mar, Barcelona.
1989-1999 Head of the Ophthalmology Department, Sagrada Familia Clinic, Barcelona, Spain.
From 2000 to present, President and CEO of the Dr. Carlos Verges Private Foundation.
2000-2007 Head of the Ophthalmology Department, Institut Universitari Dexeus, Barcelona, Spain.
2007 – present General Director of the “Advanced Ophthalmology Department Dr. Verges”, Barcelona, Spain.
2018-present President and Head of the Department of Ophthalmology. University Hospital Dexeus Quironsalud. Polytechnic University of Catalonia.
Awards :
- National Research Prize 1984. Ministry of Education and Science: "The mechanism of tear secretion. The importance of beta-adrenergic receptors in the lacrimation of the lacrimal glands."
- National Prize for the best doctoral dissertation, Shibre Medal, 1984 "Personal contribution to the study of labial secretion. Determination of beta-adrenergic receptors in tear cells"
- National Pharmaceutical Industry Award 1987: "Treatment of immunological rejection in corneal transplantation using cyclosporine A."
- American Society of Implant Refractive Surgery (ASCRS) Award for the best scientific video presented at the annual conference: "Pseudo-Real Housing". First Prize. Seattle, USA, April 1999.
- Award for the most important technical innovation of 1999 from the Spanish Society.
Implantation-refractive surgery. Speaking at the National Congress held in Madrid 1999.
- 2000 Best Scientific Contribution Award "Laser Non-Penetrating Deep Sclerectomy" presented at the American Academy of Ophthalmology Meeting, AAO - Dallas, USA, October 2000.
- Best Paper Award for “GDx Analysis of Retinal Nerve Fiber Layer Thickness after LASIK” presented at the American Society of Cataract and Refractive Surgery, ASCRS, May 2004, San Diego, USA.
- Finalist for the King Jaume I Prize for Basic Research, 2005, sponsored by the Board of Trustees of the Generalitat of Valencia and the Valencian Foundation for Advanced Research.
- Surgical Technical Video Award: "MICS under Vision ICL, The Hook Technique"
Presented at the IX International Congress of Cataract and Refractive Surgery, May/June 2006, Belo Horizonte, Brazil.
Membership in scientific societies
Member of the Executive Board of the International Society of Refractive Surgery (ISRS) and the American Academy of Ophthalmology (AAO).
Member of the editorial board of Ophthalmology Times. Europe.
Member of the editorial board of Cataract and Refractive Surgery (USA).
Member of the Editorial Board of Cataract and Refractive Surgery Today Europe.
Member of the European Society of Cataract and Refractive Surgery (ESCRS).
Scientific reviewer of the journal: Cornea, Journal of Cataract and Refractive Surgery, American Academy of Ophthalmology, Cataract and Refractive Surgery and Archives of the Spanish Society of Ophthalmology.